John S. Montalbano - 06 Mar 2025 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
06 Mar 2025
Net transactions value
+$140,568
Form type
4
Filing time
07 Mar 2025, 15:32:01 UTC
Previous filing
24 Jun 2024
Next filing
10 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $140,568 +60,000 +70% $2.34 146,000 06 Mar 2025 Direct
holding ABCL Common Shares 5,000 06 Mar 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.